Unlock instant, AI-driven research and patent intelligence for your innovation.

Indole compound as well as preparation method, pharmaceutical composition and application thereof

A technology of compound and medicinal salt, applied in the field of new indole compounds

Active Publication Date: 2019-11-22
INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, so far, no IDO1 inhibitor drugs have been marketed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Indole compound as well as preparation method, pharmaceutical composition and application thereof
  • Indole compound as well as preparation method, pharmaceutical composition and application thereof
  • Indole compound as well as preparation method, pharmaceutical composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0288] 4-((3-Chloro-4-fluorophenyl)amino)-1H-indole-2-carboxylic acid

[0289]

[0290] a) 4-((3-chloro-4-fluorophenyl)amino)-1H-indole-2-carboxylic acid ethyl ester

[0291] Dissolve methyl 4-bromoindole-2-carboxylate (170mg, 0.67mmol) in toluene (10mL) and add Pd successively 2 (dba) 3 (61mg, 0.067mmol), Davephos (53mg, 0.13mmol) and K 3 PO 4 (426mg, 2.01mmol, 2mLH 2 O), after stirring evenly, 3-chloro-4-fluoroaniline (292mg, 2.01mmol) was added, under the protection of argon, the reaction was refluxed for 4h, and the raw materials disappeared. Cool to room temperature, concentrate, add EA (30 mL) to dissolve the residue, wash with saturated brine (20 mL×3), wash with water (20 mL×2), and perform column chromatography (P / E=10:1) to obtain 250 mg of off-white solid, The eluate was washed and filtered to obtain 155 mg of white powdery solid with a yield of 73% and a melting point of 168-170°C.

[0292] 1 H-NMR (400MHz, Acetone-d 6 )δ (ppm): 10.93 (brs, 1H), 7.68 (s,...

Embodiment 2

[0297] 4-((3-Chloro-4-fluorophenyl)amino)-7-fluoro-1H-indole-2-carboxylic acid

[0298]

[0299] a) Ethyl 2-azido-3-(2-bromo-5-fluorophenyl)acrylate

[0300] Sodium metal (2.27g, 98.5mmol) was dissolved in absolute ethanol (70mL) and cooled to -15°C. 2-Bromo-5-fluorobenzaldehyde (5.0g, 24.6mmol) and ethyl azidoacetate (12.8g, 98.5mmol) were dissolved in absolute ethanol (20mL), added dropwise to the above solution, 0°C After reacting overnight, the starting material disappeared. Pour the reaction solution into NH 4 Cl aqueous solution (100 mL), extracted with EA (50 mL×3), and column chromatography (P / E=100:1) gave 3.271 g of white solid, yield 42.3%.

[0301] 1 H-NMR (400MHz, CDCl 3 )δ (ppm): 7.94 (dd, J 1 =10.0Hz,J 2 =2.8Hz,1H), 7.56(dd,J 1 =8.8Hz,J 2 =5.6Hz,1H),7.19(s,1H),6.92(dt,J 1 =8.0Hz,J 2 =2.8Hz, 1H), 4.40(q, J=7.2Hz, 2H), 1.42(t, J=7.2Hz, 3H).

[0302] b) ethyl 4-bromo-7-fluoro-1H-indole-2-carboxylate

[0303] Dissolve ethyl 2-azido-3-(2-bromo-5-fluor...

Embodiment 3

[0312] 4-((3-Chloro-4-fluorophenyl)amino)-7-chloro-1H-indole-2-carboxylic acid

[0313]

[0314] a) Ethyl 2-azido-3-(2-bromo-5-chlorophenyl)acrylate

[0315] Sodium metal (12.58mg, 0.55mol) was dissolved in absolute ethanol (100mL) and cooled to -15°C. 2-Bromo-5-chlorobenzaldehyde (80g, 0.36mol), ethyl azidoacetate (70.6g, 0.55mol), ethyl trifluoroacetate (85.4mol, 0.55mol) were added to the reaction solution,- React at 15°C for 2 hours, raise to 0°C and react overnight, the starting material disappears. Pour the reaction solution into saturated NH 4 In the aqueous Cl solution, a solid was precipitated, filtered and dried, and the filter cake column chromatography (P / E=50:1) gave 60.75 g of a white solid, with a yield of 50.4%.

[0316] 1 H-NMR (400MHz, CDCl 3 )δ (ppm): 8.13 (s, 1H), 7.53 (d, J = 8.4Hz, 1H), 7.15 (s, 2H), 4.40 (q, J = 7.2Hz, 2H), 1.42 (t, J = 7.2Hz, 3H).

[0317] b) ethyl 4-bromo-7-chloro-1H-indole-2-carboxylate

[0318] Dissolve ethyl 2-azido-3-(2-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an indole compound as well as a preparation method, a pharmaceutical composition and an application thereof. Specifically, the invention relates to an indole derivative as shown in a general formula I and a medicinal salt thereof, a preparation method of the indole derivative, a composition containing one or more compounds, and applications of the compounds in preparation of medicines for preventing and / or treating diseases related to IDO1 and / or TDO.

Description

technical field [0001] The present invention relates to a new class of indole compounds, their pharmaceutically acceptable salts, their preparation methods, pharmaceutical compositions containing said compounds, and said compounds as medicines, especially as anti-tumor drugs or as tumor-promoting drugs. Combined application of sensitizers and antineoplastic drugs. Background technique [0002] Tryptophan is an essential amino acid for the human body. There are two pathways for the metabolism of tryptophan in the body, among which the kynurenine pathway is the main metabolic pathway, which will produce a variety of biologically active small molecules. The first step of the kynurenine metabolic pathway is also the rate-limiting step, which is catalyzed by three enzymes, IDO1 (Indoleamine 2,3-dioxygenase 1), IDO2 and TDO (Tryptophan 2,3-dioxygenase). Among them, IDO1 is the most widely distributed in the body and plays a major catalytic role; TDO is mainly expressed in the li...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D209/42C07D209/08C07D209/12C07D209/30C07D209/14C07D333/70C07D405/12C07D401/12C07D403/12C07D409/12C07D417/12C07D471/04A61K31/404A61K31/381A61K31/4439A61K31/454A61K31/506A61K31/416A61K31/427A61K31/437A61P35/00
CPCC07D209/42C07D209/08C07D209/12C07D209/30C07D209/14C07D333/70C07D405/12C07D401/12C07D403/12C07D409/12C07D417/12C07D471/04A61P35/00
Inventor 徐柏玲陈晓光崔国楠来芳芳周洁季鸣王晓宇杜婷婷李陵金晶
Owner INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI